The developmental origins of disease or fetal programming model predict that early (intrauterine and/or postnatal) exposures to external insults of sufficient length and intensity may have enduring or lifelong consequences for physical and psychological health. The method described in this chapter considers an animal model to study the pathophysiological alterations connected to an HPA axis (hypothalamic-pituitary-adrenal) hyperactivity that are induced by an early-life stressful procedure involving the opioid system.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/978-1-0716-0884-5_23 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Psychostimulant and opioid abuse: A perspective from Uruguay.
Neuroscience
March 2025
Departamento de Neurofarmacología Experimental, Instituto de Investigaciones Biológicas Clemente Estable, Montevideo, Uruguay. Electronic address:
The number of people suffering from Substance Use Disorder (SUD) worldwide has increased 45 % compared to the last decade according to the latest United Nations World Drug Report. This staggering increase, partly due to the recent COVID-19 pandemic, further raises the social and economic burden for nations. Prevention and treatment, two of the main strategies employed to curb the increase in SUD, have shown limited success despite our increasing understanding of the underlying processes of SUD.
View Article and Find Full Text PDFThe Fourth Wave of the Opioid Epidemic: Increasing Combination of Fentanyl With Stimulants.
Am J Public Health
April 2025
All authors are with the Office of the Chief Medical Examiner, San Francisco, CA. Luke N. Rodda is also with the Department of Laboratory Medicine, University of California, San Francisco.
To identify drug prevalence through the analysis of drug material and paraphernalia (DMP) collected from scenes of fentanyl-involved fatal accidental drug overdoses in San Francisco, California, throughout 2022. We conducted gas chromatography-mass spectrometry testing on 409 items of DMP (e.g.
View Article and Find Full Text PDFDecriminalization undone: Assessing the amendment to British Columbia's decriminalization of personal drug possession framework.
Can J Public Health
March 2025
Faculty of Health Sciences, Simon Fraser University, Burnaby, BC, Canada.
The Province of British Columbia (BC) is in the midst of an ongoing public health emergency, declared in 2016 in response to significant levels of drug poisonings/overdoses stemming from the unregulated drug supply. In response, BC implemented decriminalization in 2023, removing criminal sanctions for adults possessing up to 2.5 cumulative grams of opioids, cocaine, methamphetamine, and MDMA.
View Article and Find Full Text PDFSuboptimal care and inappropriate opioid use in chronic pain: A critical analysis of two case studies and healthcare expenditure burden.
J Opioid Manag
March 2025
SA Pharmacy, Government of South Australia, Adelaide, Australia. ORCID: https://orcid.org/0000-0003-4786-022X.
Introduction: Chronic pain is a leading cause of chronic disease in Australia, with a 2020 report indicating that one in five Australians aged over 45 experience chronic pain. The high prevalence of chronic pain accounts for significant healthcare utilization and associated costs, with the economic impact of chronic pain estimated to be AUD$139 billion in 2018.
Case Presentations: This paper uses two exemplar cases to demonstrate inadequacies within the current systems supporting those with chronic pain and the associated impacts these inadequacies have on patient outcomes and healthcare costs.
Development of a standardized protocol for buprenorphine induction in a chronic pain clinic.
J Opioid Manag
March 2025
Outpatient Chronic Pain Clinical Pharmacist Practitioner, VA Salt Lake City Health Care System, Salt Lake City, Utah.
Objective: Create a standardized protocol document on how to convert patients from full opioid agonist to buprenorphine. Providing patients with the best possible chance of a seamless conversion resulting in decreased risk of failure of therapy with buprenorphine.
Methods: A 10-question survey was distributed to better understand the different aspects the providers consider when converting a patient from full opioid agonist to buprenorphine.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!